Thus, GFRAL-triggered signaling cannot explain all of GDF15-mediated effects reported by us and others in the context of lung fibrosis (23, 34), cancer progression (69, 70), or cardiac disease (65), as was also recently reviewed by Wischhusen et al. (71). The gene discussed is GDF15; the disease is cancer.